or Try an Advanced Search...

    Disorders Stocks List

    Symbol Grade Name % Change
    CORT B Corcept Therapeutics Incorporated 1.65
    ELYM B Eliem Therapeutics, Inc -5.47
    LFST C LifeStance Health Group, Inc. -3.65
    ELDN C Eledon Pharmaceuticals, Inc. -3.75
    IGC C India Globalization Capital Inc. -0.96
    DXR C Daxor Corporation -1.25
    REGN C Regeneron Pharmaceuticals, Inc. 0.60
    CPRX C Catalyst Pharmaceutical Partners, Inc. 1.85
    CGTX C Cognition Therapeutics, Inc. 1.57
    IBIO C iBio, Inc. -1.60
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Medicine Biopharmaceutical Biotechnology Epilepsy Pain Pharmaceutical Psychiatric Diagnosis Alzheimer's Disease Clinical Research Depression Geriatrics Health Sciences Medication Parkinson's Disease Abnormal Psychology Aging Associated Diseases Anemia Angioedema Angiogenesis Anthrax

    Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

    Symbol Grade Name Weight
    FBT D First Trust Amex Biotech Index Fund 10.07
    PJP A PowerShares Dynamic Pharmaceuticals 9.73
    IBB C iShares Nasdaq Biotechnology Index Fund 8.22
    PBE C PowerShares Dynamic Biotech & Genome 7.97
    IBBQ B Invesco Nasdaq Biotechnology ETF 7.91
    View all Disorders ETFs...
    Compare ETFs
    Compare FBT to PBE Compare IBB to IBBQ Compare PJP to IBBQ

        Disorders Stocks Recent News

        Date Stock Title
        May 10 REGN Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock continues to impress, up 3.2% over the past week
        May 10 REGN Q1 2024 Intellia Therapeutics Inc Earnings Call
        May 9 CPRX HHS panel to vote in Nov. on DMD screening for newborns
        May 9 CPRX Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript
        May 9 ELDN Eledon Pharmaceuticals GAAP EPS of -$0.34 beats by $0.04
        May 9 ELDN Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
        May 9 ELDN Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
        May 9 REGN Regeneron’s gene therapy triumphs twice, restoring hearing in children
        May 8 CPRX Catalyst Pharmaceuticals Non-GAAP EPS of $0.38 beats by $0.08, revenue of $98.44M misses by $0.33M
        May 8 CPRX Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
        May 8 REGN Regeneron gene therapy improves hearing in child deafness
        May 8 REGN Regeneron gene therapy improves hearing in two children
        May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
        May 7 CPRX Catalyst Pharmaceuticals Q1 2024 Earnings Preview
        May 7 CGTX Cognition Therapeutics GAAP EPS of -$0.27
        May 7 CGTX Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
        May 7 ELDN Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
        May 7 ELDN Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
        May 6 REGN Regeneron Announces Investor Conference Presentations
        May 6 REGN Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Medicine Biopharmaceutical Biotechnology Epilepsy Pain Pharmaceutical Psychiatric Diagnosis Alzheimer's Disease Clinical Research Depression Geriatrics Health Sciences Medication Parkinson's Disease Abnormal Psychology Aging Associated Diseases Anemia Angioedema Angiogenesis Anthrax
        Disorders

        Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

        More about Disorders
        Browse All Tags